U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07909031) titled 'CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors' on Oct. 20.
Brief Summary: The purpose of this study is to determine the safety and tolerability of monotherapy CR-002 and to identify the MTD and/or optimal biologic dose and RP2D(s) in participants with locally advanced or metastatic solid tumors.
Study Start Date: Oct. 21
Study Type: INTERVENTIONAL
Condition:
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
Gastric/GEJ
Biliary Tract Cancer (BTC)
Esophageal Squamous Cell Carcinoma (ESCC)
Ovarian Cancer
Endometrial Cancer
Cervical Cancer Metastatic
Non-small Cell Lung Cancer ...